NCT02546219View on ClinicalTrials.gov

a4b7 Integrin in Eosinophilic Esophagitis

CompletedOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Eosinophilic Esophagitis
Interventions
OTHER

Eosinophil isolation and characterization.

Peripheral blood and esophageal biopsies will be obtained from study subjects for further analysis of eosinophils integrin profiles.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT02546219 - a4b7 Integrin in Eosinophilic Esophagitis | Biotech Hunter | Biotech Hunter